Logo image
The role of Prohibitin-1 in cardiac development, function and metabolism
Dissertation   Open access

The role of Prohibitin-1 in cardiac development, function and metabolism

Ran Huo
University of Iowa
Doctor of Philosophy (PhD), University of Iowa
Summer 2024
DOI: 10.25820/etd.007694
pdf
Thesis_Ran Huo_07243.23 MBDownloadView
Open Access Free to read and download

Abstract

Prohibitins (PHB1/2) are highly conserved lipid-raft associated membrane proteins ubiquitously expressed in all cell types and localized to multiple compartments, particularly abundant in mitochondria. PHBs are associated with numerous signaling pathways responsible for cell differentiation, growth, and metabolism. In mitochondria, PHBs form a large, ring-shaped complex and play crucial roles in stabilizing mitochondrial cristae, maintaining mitochondrial dynamics, and supporting mitochondrial biogenesis. Given their diverse roles in mitochondrial function, PHBs have been found to be altered in various pathological conditions, such as liver injury, diabetes, cancer, and obesity, However, the role of PHBs in heart is understudied. To determine the role that PHB1 plays in cardiac function, we first established a cardiac-specific PHB1-deficient mouse strain (PHBfl/fl, MHC-Cre+/-, cKO). Unexpectedly, the vast majority of cKO mice died in utero during pregnancy. The few that were born develop severe dilated cardiomyopathy, resulting in mortality by 8-9 weeks of age. Heart weight/body weight ratio is ~2-fold greater in the cKO mice vs. WT. Echocardiography reveals severely enlarged right atria and ventricles in cKO mice, corresponding to significantly decreased ejection faction (EF), increased end diastolic volume (EDV) and end systolic volume (ESV) compared to wild-type (WT) littermates (P < 0.05). Uterine sonography of the expired cKO embryos showed significantly decreased crown-rump length and increased placenta thickness with large amount of fluids, restricted uterine artery flow and detachment between amnion and chorion compared with normal embryos (P < 0.001). After embryonic day 14.5, the mortality rate among the cKO embryos increased and was associated with abnormal hemorrhage. Histological analyses confirmed that the absence of PHB1 in these embryos led to lethal cardiac defects, including significant cardiac malformations and myocardial thinning. Due to high embryonic lethality, we generated a tamoxifen-inducible, cardiomyocyte-specific PHB1 knockout (PHB1fl/fl, MHC-MerCreMer+/-) mouse model. 6 weeks after tamoxifen injection, cardiomyocyte PHB1 expression was ~90% absent in adult cPHB1KO mice compared with WT, yet cardiac function remained normal. However, 12 weeks following tamoxifen, the cPHB1KO mice exhibited severe dilated cardiomyopathy, with female mice dying earlier than male mice. At 6 weeks post-tamoxifen, the cPHB1KO mice had normal cardiac function, mitochondrial respiration, and ATP production, along with observed changes in respiratory chain protein subunits and supercomplex formation. Additionally, both male and female cPHB1KO mice exhibited increased mitochondrial Ca2+ uptake, with females showing greater Ca2+ retention capacity. In situ confocal imaging indicated lower mitochondrial membrane potential and higher ROS production in female cPHB1KO mice compared to males. According to the transcriptomics and metabolomics data, 6-week post-tamoxifen cPHB1KO mice exhibited a considerable increase in the expression of genes associated with glutamine metabolism, coupled with a decline in fatty acid oxidation and glycolysis-related genes. This metabolic shift was mirrored by notably reduced glutamine levels within cardiac tissue, indicating glutamine metabolism serves as a bioenergetic adaptation to compensate energy defects and maintain the efficiency of the tricarboxylic acid (TCA) cycle. To validate these findings, cPHB1KO mice subjected to a high-glutamine diet over a 10-week period exhibited an extended lifespan and increased ejection fraction compared to mice without glutamine supplementation. Taken together, our findings demonstrate that the critical role of PHB1 in both heart development and the regulation of mitochondrial homeostasis and cardiac metabolism in heart failure pathogenesis. We also provide a rationale for glutamine supplementation as a therapeutic strategy for managing cardiomyopathies induced by mitochondrial dysfunction.
Heart Failure Pharmacology mitochondria prohibitins

Details

Metrics

5 File views/ downloads
39 Record Views
Logo image